Charles Schwab’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$383K Sell
123,050
-14,521
-11% -$45.2K ﹤0.01% 3230
2025
Q1
$465K Hold
137,571
﹤0.01% 3106
2024
Q4
$780K Buy
137,571
+94
+0.1% +$533 ﹤0.01% 2994
2024
Q3
$804K Buy
137,477
+3,473
+3% +$20.3K ﹤0.01% 2991
2024
Q2
$1.06M Buy
134,004
+19,552
+17% +$155K ﹤0.01% 2915
2024
Q1
$1.07M Buy
114,452
+29,715
+35% +$277K ﹤0.01% 2778
2023
Q4
$715K Sell
84,737
-3,436
-4% -$29K ﹤0.01% 2946
2023
Q3
$683K Buy
88,173
+3,118
+4% +$24.2K ﹤0.01% 2928
2023
Q2
$974K Buy
85,055
+72,609
+583% +$831K ﹤0.01% 2776
2023
Q1
$96K Hold
12,446
﹤0.01% 3252
2022
Q4
$75.9K Hold
12,446
﹤0.01% 3294
2022
Q3
$74K Hold
12,446
﹤0.01% 3250
2022
Q2
$74K Sell
12,446
-3,464
-22% -$20.6K ﹤0.01% 3324
2022
Q1
$122K Buy
+15,910
New +$122K ﹤0.01% 3387
2021
Q3
Sell
-114,256
Closed -$472K 3544
2021
Q2
$472K Sell
114,256
-50,623
-31% -$209K ﹤0.01% 3182
2021
Q1
$777K Sell
164,879
-5,011
-3% -$23.6K ﹤0.01% 2935
2020
Q4
$1.22M Buy
169,890
+2,663
+2% +$19K ﹤0.01% 2717
2020
Q3
$1.79M Buy
167,227
+549
+0.3% +$5.86K ﹤0.01% 2526
2020
Q2
$2.1M Sell
166,678
-39,424
-19% -$498K ﹤0.01% 2405
2020
Q1
$1.89M Buy
206,102
+1,515
+0.7% +$13.9K ﹤0.01% 2297
2019
Q4
$2.85M Buy
204,587
+5,299
+3% +$73.9K ﹤0.01% 2300
2019
Q3
$3.43M Buy
199,288
+59,372
+42% +$1.02M ﹤0.01% 2159
2019
Q2
$3.81M Buy
139,916
+14,647
+12% +$399K ﹤0.01% 2106
2019
Q1
$2.4M Buy
125,269
+11,269
+10% +$216K ﹤0.01% 2301
2018
Q4
$1.07M Sell
114,000
-1,987
-2% -$18.7K ﹤0.01% 2522
2018
Q3
$2.2M Buy
115,987
+14,411
+14% +$273K ﹤0.01% 2402
2018
Q2
$1.99M Buy
101,576
+14,849
+17% +$290K ﹤0.01% 2381
2018
Q1
$1.63M Buy
86,727
+9,689
+13% +$182K ﹤0.01% 2388
2017
Q4
$1.28M Buy
77,038
+27,250
+55% +$452K ﹤0.01% 2446
2017
Q3
$1.03M Buy
49,788
+20,753
+71% +$428K ﹤0.01% 2503
2017
Q2
$261K Buy
29,035
+114
+0.4% +$1.03K ﹤0.01% 2920
2017
Q1
$383K Buy
28,921
+1,026
+4% +$13.6K ﹤0.01% 2737
2016
Q4
$356K Buy
27,895
+924
+3% +$11.8K ﹤0.01% 2776
2016
Q3
$324K Buy
26,971
+690
+3% +$8.29K ﹤0.01% 2761
2016
Q2
$289K Buy
26,281
+9,010
+52% +$99.1K ﹤0.01% 2798
2016
Q1
$151K Buy
17,271
+255
+1% +$2.23K ﹤0.01% 2944
2015
Q4
$373K Buy
+17,016
New +$373K ﹤0.01% 2774